WCLC 2025 - Posters & ePosters-P3.03.29 IAM1363 Is a Potent, Selective, and Irreversible HER2 and Pan-HER2 Mutant Small Molecule Inhibitor for the Treatment of HER2-Driven NSCLC

P3.03.29 IAM1363 Is a Potent, Selective, and Irreversible HER2 and Pan-HER2 Mutant Small Molecule Inhibitor for the Treatment of HER2-Driven NSCLC

Asset Subtitle

Zhongdong Huang

Meta Tag

Speaker Zhongdong Huang

Topic Tumor Biology – Translational Biology